Alexion Pharmaceuticals
Alexion Pharmaceuticals (ALXN) is a world-renowned biotechnology company. The company was founded in 1992 and is headquartered in Connecticut, USA. The company launched Soliris (eculizumab injection) in 2007, which was the world's first drug for the treatment of paroxysmal nocturnal hemoglobinuria (PNH), helping the company achieve great success.